Reach Us +1-217-403-9671
Cellular And Molecular Actions Of Growth Factors | 33933
ISSN: 2376-0419

Journal of Pharmaceutical Care & Health Systems
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Cellular and molecular actions of growth factors

European Pharma Congress

Mahmoud Balbaa

Alexandria University, Egypt

ScientificTracks Abstracts: J Pharma Care Health Sys

DOI: 10.4172/2376-0419.S1.005

Growth factors and their receptors are important signaling molecules, which are involved in the regulation of cell growth. There are different types of growth factors causing different responses andthere are many overlapping responses from some types. Epidermal Growth Factor (EGF) stimulates the phosphorylation of the ribosomal protein S6, whereas the activation of its receptor (EGFR) is associated with metastasis, poor prognosis and chemotherapy resistance. This receptor is over expressed in epithelial malignancies. Transforming Growth Factor Beta (TGFβ-1) is a multifunctional type involved in the regulation of growth and differentiation of both normal and transformed cells and overexpressed in hepatocellular carcinoma tissues. A significantly higher serum level of EGF and TGF-β1was recently found in patients with hepatocellular carcinoma compared to their level in patients with chronic hepatitis C infection and control subjects. The levels of phosphorylated EGFR in hepatocellular carcinoma and chronic hepatitis C patients showed a highly significant difference between patients. Taken together, EGF and its phosphorylated form can be used as sensitive biomarkers for the diagnosis and prognosis of these diseases. In conclusion, various growth factors are involved in different biological processes, some of which have a clinical importance in disease.

Mahmoud Balbaa is a Professor of Biochemistry in Faculty of Science at Alexandria University, Egypt. He used to be a Head of the Department of Biochemistry at the same faculty from 2007 to 2009. He obtained his PhD degree from Hokkaido University, Japan in 1988 and worked in the field of protein phosphorylation, enzyme characterization in disease and enzyme inhibition at Faculty of Science, Alexandria University. He worked as a Professor of biochemistry in Beirut Arab University (2009–2014) and University of Qatar (2002–2006). In addition, he was a Postdoctoral Fellow of Hokkaido University School of Medicine and Faculty of Medicine, University of Toronto. He published more than 45 papers and serving as a Reviewer in some peer review journals. He is a Member of the Editorial Board of Biochemistry & Physiology: Open access.

Email: [email protected]